Early Phase Clinical Trial Units (EPCTU)
Awarded Award Notice Posted
- Solicitation number
- 75N93022D00017
- Agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- Awarded
- to PPD Development LP
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93022D00017 Federal IDV award
Notice details come from SAM.gov. Updated .
About this opportunity
The Award Notice from the National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a contract to PPD Development, L.P. to conduct Phase 0 through Phase II clinical trials, including proof-of-concept studies, domestically and internationally, to evaluate investigational products such as small molecules, monoclonal antibodies, vaccines, and other immunomodulatory products against infectious diseases. The contract has a value of $346,610,277, awarded on January 14, 2022 to fulfill the requirements of Request for Proposal RFP-NIAID-NIH-AI-75N93020R00023 which sought proposals for Early Phase Clinical Trial Units with a minimum value of $10,000 and maximum value of $346,610,277.
Notice text
See Attachment for RFP-NIAID-NIH-AI-75N93020R00023.
Awarded contract 75N93022D00017 to PPD Development, L.P. for 346610277.00 on 2022-01-14.
Attachments
| File | Type | Posted |
|---|---|---|
| RFP-NIAID-NIH-AI-75N93020R00023 Final.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Solicitation | |
| Early Phase Clinical Trial Units (EPCTU) | Pre-Solicitation |
And 1 more award notice.
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity